Table 5 The prevalence of patients with pCR in BCS and mastectomy groups
From: Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
pCR | BCS | Mastectomy |
|---|---|---|
Overall pCR in both breast and axilla | 55 (76.4%) | 31 (41.3%) |
From: Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
pCR | BCS | Mastectomy |
|---|---|---|
Overall pCR in both breast and axilla | 55 (76.4%) | 31 (41.3%) |